GO:0004392 heme oxygenase (decyclizing) activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004392 describes the enzymatic activity that converts heme b into biliverdin, carbon monoxide (CO), and free iron (Fe2+) using molecular oxygen and reducing equivalents from NADPH-hemoprotein reductase.
• The reaction is a three-step oxidative cleavage of the heme tetrapyrrole ring, unique among oxygenases because it uses heme both as substrate and as prosthetic group.
• Heme oxygenase-1 (HMOX1) is the inducible isoform, while heme oxygenase-2 (HMOX2) is constitutively expressed; both catalyze the same decyclizing reaction but differ in regulation and tissue distribution.
• The products biliverdin, CO, and Fe2+ have potent biological activities, including antioxidant, anti-inflammatory, and signaling roles, making this activity central to cytoprotection and redox homeostasis.
• Dysregulation of heme oxygenase activity is implicated in hematological malignancies, cardiovascular disease, and neurodegenerative conditions, and inhibitors are being explored as anticancer agents.
• Studying GO:0004392 requires integrated approaches such as enzyme activity assays, knockout and knock-in cell models, and CRISPR-based screens to dissect isoform-specific functions.
Description
Heme oxygenase (decyclizing) activity, encoded by the Gene Ontology term GO:0004392, is a molecular function that catalyzes the oxidative degradation of heme b to biliverdin, carbon monoxide, and ferrous iron. This reaction is the rate-limiting step in heme catabolism and is essential for recycling iron and preventing the accumulation of free heme, a pro-oxidant and pro-inflammatory molecule. The activity is carried out by heme oxygenase enzymes, which are unusual among oxygenases because they use heme as both substrate and cofactor. Researchers study this activity to understand iron homeostasis, oxidative stress responses, and the signaling roles of its gaseous product CO. The reaction consumes three molecules of molecular oxygen and three reducing equivalents provided by NADPH-hemoprotein reductase, yielding biliverdin, CO, Fe2+, and water. Because of its central role in redox biology, heme oxygenase activity is a target for therapeutic modulation in cancer, inflammation, and neurodegenerative diseases.
heme oxygenase (decyclizing) activity At A Glance
| GO ID | GO:0004392 |
|---|---|
| GO term | heme oxygenase (decyclizing) activity |
| Ontology | molecular_function |
| Synonym | haem oxygenase activity; heme oxidase activity; heme oxygenase activity; ORP33 proteins |
| Major function | Catalyzes the oxidative cleavage of heme b to biliverdin, CO, and Fe2+ using O2 and NADPH-hemoprotein reductase |
| Reaction | heme b + 3 O2 + 3 reduced [NADPH-hemoprotein reductase] = biliverdin + CO + Fe2+ + H+ + 3 H2O + 3 oxidized [NADPH-hemoprotein reductase] |
| Cofactor | Heme itself serves as both substrate and prosthetic group; NADPH-hemoprotein reductase provides reducing equivalents |
| Subcellular location | Endoplasmic reticulum membrane (for HMOX1 and HMOX2) |
| Key isoforms | HMOX1 (inducible), HMOX2 (constitutive) |
What Is GO:0004392?
In simple terms, GO:0004392 describes the catalytic activity that breaks open the heme ring to release iron, carbon monoxide, and biliverdin. According to the QuickGO definition, it catalyzes the reaction: heme b + 3 O2 + 3 reduced [NADPH-hemoprotein reductase] = biliverdin + CO + Fe2+ + H+ + 3 H2O + 3 oxidized [NADPH-hemoprotein reductase]. This activity is also known as heme oxygenase activity, haem oxygenase activity, or heme oxidase activity. It is a molecular function that requires molecular oxygen and reducing equivalents and produces three distinct bioactive products.
Why Is heme oxygenase (decyclizing) activity Important in Cell Biology?
Heme oxygenase (decyclizing) activity is critical for maintaining iron homeostasis, protecting cells from oxidative stress, and generating signaling molecules such as carbon monoxide and biliverdin. Because heme is a pro-oxidant and pro-inflammatory molecule, its controlled degradation is essential for cellular survival under stress conditions. The activity also plays a role in the pathogenesis of hematological malignancies, where it can influence cell proliferation and apoptosis. Inhibitors of heme oxygenase-1 have shown antiproliferative activity in vitro, highlighting the therapeutic potential of targeting this activity. Furthermore, exercise has been shown to increase heme oxygenase activity in healthy volunteers, indicating its relevance to physiological adaptation.
• Maintains iron homeostasis by releasing iron from heme for recycling.
• Protects against oxidative stress by degrading free heme, a pro-oxidant.
• Produces carbon monoxide, a signaling gas that modulates inflammation and vascular tone.
• Generates biliverdin, which is rapidly converted to the antioxidant bilirubin.
• Implicated in hematological malignancies; HO-1 expression supports tumor survival.
• Target for anticancer drug discovery; HO-1 inhibitors show antiproliferative activity.
• Modulates cis-aconitase activity in lens epithelial cells, linking heme degradation to iron-sulfur cluster homeostasis.
• Involved in exercise-induced adaptive responses in healthy individuals.
• Heme oxygenase-2 is a therapeutic target for neurological disorders due to its constitutive expression.
• Essential for normal development; HO-1 deficiency in humans causes severe inflammation and iron overload.
What Happens During heme oxygenase (decyclizing) activity?
Substrate binding and heme orientation
In simple terms: The enzyme grabs heme and holds it in a specific orientation to prepare for cleavage.
Heme oxygenase binds heme b as its substrate and prosthetic group, with the heme iron coordinated by a conserved histidine residue. The enzyme ensures that the alpha-meso carbon of the heme ring is positioned for attack by molecular oxygen. This binding induces a conformational change that facilitates the subsequent steps of the reaction.
First oxygenation: alpha-meso hydroxylation
In simple terms: Oxygen is added to one specific carbon of the heme ring, forming a hydroxyl group.
The first step involves the activation of molecular oxygen and its addition to the alpha-meso carbon of heme, forming alpha-meso-hydroxyheme. This reaction requires reducing equivalents from NADPH-hemoprotein reductase. The hydroxylated intermediate is unstable and rapidly proceeds to the next step.
Second oxygenation: verdoheme formation
In simple terms: The ring opens further, releasing carbon monoxide and creating a green pigment intermediate.
The alpha-meso-hydroxyheme undergoes a second oxygenation reaction, accompanied by the release of carbon monoxide and the formation of verdoheme. This step is unique because it generates CO, a signaling molecule. The verdoheme intermediate is then converted to biliverdin in the final step.
Final step: biliverdin and iron release
In simple terms: The ring is completely opened, releasing free iron and biliverdin.
In the final step, verdoheme is converted to biliverdin with the release of ferrous iron (Fe2+). Biliverdin is subsequently reduced to bilirubin by biliverdin reductase. The released iron is recycled or stored, and the entire reaction consumes three molecules of O2 and three reducing equivalents.
Key Genes Involved in GO:0004392 heme oxygenase (decyclizing) activity
The following genes encode proteins that either catalyze heme oxygenase (decyclizing) activity or directly regulate its function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HMOX1 | Inducible heme oxygenase-1; catalyzes heme degradation | Stress response, inflammation, cancer, cardiovascular disease |
| HMOX2 | Constitutive heme oxygenase-2; catalyzes heme degradation | Neuronal function, therapeutic target for neurological disorders |
| BLVRA | Biliverdin reductase A; reduces biliverdin to bilirubin | Antioxidant defense, cellular signaling |
| BLVRB | Biliverdin reductase B; reduces biliverdin to bilirubin | Redox homeostasis, erythroid differentiation |
| NPR1 | NADPH-hemoprotein reductase; provides reducing equivalents | Electron transfer for heme oxygenase activity |
| CYB5A | Cytochrome b5; can supply electrons for heme oxygenase | Modulates heme oxygenase activity |
| HSPA1A | Heat shock protein 70; chaperone for HMOX1 | Protein folding and stability |
| HSPA5 | GRP78; ER chaperone involved in HMOX1 processing | ER stress response |
| KEAP1 | Negative regulator of NRF2; controls HMOX1 induction | Oxidative stress response |
| NFE2L2 | NRF2; transcription factor inducing HMOX1 | Antioxidant response element signaling |
| BACH1 | Repressor of HMOX1 transcription | Heme sensing and gene regulation |
| IL10 | Anti-inflammatory cytokine; induces HMOX1 | Inflammation resolution |
| TNF | Pro-inflammatory cytokine; modulates HMOX1 expression | Inflammatory signaling |
| STAT3 | Transcription factor; regulates HMOX1 expression | Cancer and immune signaling |
| MAPK1 | ERK2; signaling kinase affecting HMOX1 expression | Stress-activated pathways |
| AKT1 | Kinase modulating HMOX1 via NRF2 | Cell survival signaling |
| TP53 | Tumor suppressor; can regulate HMOX1 | Cancer biology |
| CASP3 | Apoptosis effector; affected by heme oxygenase products | Cell death pathways |
How Is heme oxygenase (decyclizing) activity Regulated?
Heme oxygenase (decyclizing) activity is regulated at multiple levels. HMOX1 is transcriptionally induced by NRF2 in response to oxidative stress, and repressed by BACH1 under basal conditions. Inflammatory cytokines such as IL-10 and TNF modulate HMOX1 expression. The activity can also be regulated by post-translational modifications and by the availability of reducing equivalents from NADPH-hemoprotein reductase. Heme oxygenase-2 is constitutively expressed and may be regulated by calcium signaling and phosphorylation. Inhibitors and activators of heme oxygenase-2 have been developed as therapeutic tools.
heme oxygenase (decyclizing) activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HMOX1 | Hematological malignancies, inflammation | Knockout and overexpression in leukemia cell lines |
| HMOX2 | Neurodegeneration, pain | Knockout mice and neuronal cell models |
| BLVRA | Antioxidant defense, cancer | Overexpression and knockout in cancer cells |
| NFE2L2 | Oxidative stress-related diseases | CRISPR knockout in stress models |
| BACH1 | Cancer, inflammation | Point mutation and knockout models |
Hematological malignancies
Heme oxygenase-1 is often overexpressed in hematological malignancies, where it supports tumor cell survival and resistance to therapy. The enzyme's products, particularly CO and biliverdin, contribute to a pro-tumorigenic microenvironment by suppressing immune responses and promoting angiogenesis. Inhibitors of heme oxygenase-1 have shown antiproliferative activity in vitro, suggesting a therapeutic strategy for these cancers.
Neurodegenerative disorders
Heme oxygenase-2 is constitutively expressed in neurons and is a therapeutic target for neurodegenerative conditions. Dysregulation of heme oxygenase activity can lead to iron accumulation and oxidative stress, contributing to neuronal damage. Modulators of HO-2 activity are being explored for neuroprotection.
Cardiovascular and inflammatory diseases
Heme oxygenase-1 induction protects against vascular injury and inflammation by degrading pro-oxidant heme and generating CO and biliverdin. The activity is also increased after exercise in healthy volunteers, indicating a role in physiological adaptation. In lens epithelial cells, heme oxygenase-1 induction modulates cis-aconitase activity, linking heme degradation to iron-sulfur cluster homeostasis.
From heme oxygenase (decyclizing) activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does HMOX1 knockout affect tumor growth? | HMOX1 knockout cancer cell lines and xenografts |
| What is the effect of a specific point mutation in HMOX1 on enzyme activity? | Point-mutation knock-in cell lines |
| Can we tag HMOX1 to track its localization? | Knock-in of fluorescent or epitope tags |
| Does HMOX2 overexpression protect neurons? | Overexpression in neuronal cell lines |
| Which genes modulate heme oxygenase activity? | CRISPR library screening |
| How does HMOX1 induction affect cis-aconitase activity? | Knockout and overexpression in lens epithelial cells |
How to Study the heme oxygenase (decyclizing) activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Spectrophotometric bilirubin assay | Heme oxygenase activity | Enzyme kinetics and inhibitor testing |
| HPLC | Biliverdin and bilirubin levels | Quantification in cell lysates |
| RNA-seq | HMOX1/HMOX2 mRNA expression | Transcriptional regulation studies |
| Western blot | Protein levels of HMOX1/HMOX2 | Induction and stability assays |
| CRISPR knockout screens | Genes affecting heme oxygenase activity | Functional genomics |
| Metabolomics | Biliverdin, bilirubin, CO | Pathway flux analysis |
| Immunofluorescence | Subcellular localization of HMOX1/2 | ER localization studies |
| CO measurement | Carbon monoxide production | Signaling studies |
Enzyme activity assays
Heme oxygenase activity is typically measured by quantifying bilirubin or biliverdin production using spectrophotometric or HPLC-based assays. These assays can be performed in cell lysates or with purified enzyme and require NADPH and NADPH-hemoprotein reductase.
Gene expression analysis
RNA-seq and qPCR are used to measure HMOX1 and HMOX2 mRNA levels under various conditions. Western blotting detects protein levels and can assess induction by stressors.
CRISPR-based screens
Genome-wide CRISPR knockout or activation screens can identify genes that regulate heme oxygenase activity or its downstream effects. These screens are useful for discovering novel modulators and drug targets.
Metabolite profiling
Mass spectrometry-based metabolomics can quantify biliverdin, bilirubin, and CO production to assess flux through the heme degradation pathway. This approach is valuable for understanding the metabolic impact of heme oxygenase activity.
How CRISPR Can Be Used to Study GO:0004392 heme oxygenase (decyclizing) activity
Knockout
CRISPR knockout of HMOX1 or HMOX2 allows researchers to study the loss of heme oxygenase activity and its consequences on cell survival, oxidative stress, and iron homeostasis. Knockout cell lines are valuable for validating inhibitor specificity and for identifying compensatory pathways.
Point Mutation
Introducing point mutations in the catalytic residues of HMOX1 or HMOX2 can dissect the mechanism of heme cleavage and the role of specific amino acids in substrate binding and catalysis. Such models help confirm the enzymatic mechanism and identify residues critical for activity.
Knock-in
Knock-in of tags (e.g., FLAG, GFP) into the endogenous HMOX1 or HMOX2 loci enables real-time tracking of protein localization and interaction partners without overexpression artifacts. This approach is useful for studying ER membrane dynamics and protein trafficking.
Overexpression
Overexpression of HMOX1 or HMOX2 in cell lines is used to study the protective effects of increased heme oxygenase activity against oxidative stress and inflammation. Overexpression models also help evaluate the therapeutic potential of enhancing this activity.
How EDITGENE Supports heme oxygenase (decyclizing) activity Research
Researchers studying heme oxygenase (decyclizing) activity-related genes often need to determine whether a candidate gene is causally involved in heme degradation, stress responses, or disease phenotypes. EDITGENE provides comprehensive CRISPR-based services to create precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for heme oxygenase (decyclizing) activity research.
Frequently Asked Questions About heme oxygenase (decyclizing) activity
What is heme oxygenase (decyclizing) activity?
It is the enzymatic activity defined by GO:0004392 that converts heme b into biliverdin, carbon monoxide, and free iron using oxygen and reducing equivalents.
What genes are involved in heme oxygenase (decyclizing) activity?
The main genes are HMOX1 and HMOX2, which encode the inducible and constitutive isoforms of heme oxygenase, respectively.
What is the reaction catalyzed by heme oxygenase?
The reaction is: heme b + 3 O2 + 3 reduced [NADPH-hemoprotein reductase] = biliverdin + CO + Fe2+ + H+ + 3 H2O + 3 oxidized [NADPH-hemoprotein reductase].
How is heme oxygenase activity measured?
It is commonly measured by spectrophotometric or HPLC-based assays that quantify bilirubin or biliverdin production.
What diseases are associated with heme oxygenase activity?
It is implicated in hematological malignancies, neurodegenerative disorders, and cardiovascular diseases.
Can heme oxygenase activity be inhibited?
Yes, inhibitors of heme oxygenase-1 have been developed and show antiproliferative activity in vitro.
What is the difference between HMOX1 and HMOX2?
HMOX1 is inducible by stress, while HMOX2 is constitutively expressed and predominantly found in neurons.
How does exercise affect heme oxygenase activity?
Heme oxygenase activity increases after exercise in healthy volunteers.
What are the products of heme oxygenase activity?
The products are biliverdin, carbon monoxide, and ferrous iron.
How can CRISPR be used to study heme oxygenase activity?
CRISPR can create knockout, point mutation, knock-in, or overexpression models to dissect gene function and regulation.
Conclusion
Heme oxygenase (decyclizing) activity (GO:0004392) is a fundamental enzymatic function that governs heme catabolism, iron recycling, and the production of bioactive gases and antioxidants. Its dysregulation is linked to cancer, neurodegeneration, and inflammatory diseases, making it a compelling therapeutic target. Advances in CRISPR-based models and screening technologies are accelerating our understanding of this activity and its regulatory networks. Continued research into heme oxygenase biology promises to yield new strategies for modulating this pathway in human disease.
References
- 1. Montellano PR. 2000. The mechanism of heme oxygenase.. Curr Opin Chem Biol 4(2):221-7 PMID: 10742194
- 2. Wilks A. 2002. Heme oxygenase: evolution, structure, and mechanism.. Antioxid Redox Signal 4(4):603-14 PMID: 12230872
- 3. Ghio AJ et al.. 2018. Heme oxygenase activity increases after exercise in healthy volunteers.. Free Radic Res 52(2):267-272 PMID: 29343136
- 4. Intagliata S et al.. 2019. Heme Oxygenase-2 (HO-2) as a therapeutic target: Activators and inhibitors.. Eur J Med Chem 183:111703 PMID: 31550661
- 5. Li Volti G et al.. 2017. The Heme Oxygenase System in Hematological Malignancies.. Antioxid Redox Signal 27(6):363-377 PMID: 28257621
- 6. Rzymkiewicz DM et al.. 2000. Induction of heme oxygenase-1 modulates cis-aconitase activity in lens epithelial cells.. Biochem Biophys Res Commun 270(1):324-8 PMID: 10733947
- 7. Yoshida T et al.. 2000. Mechanism of heme degradation by heme oxygenase.. J Inorg Biochem 82(1-4):33-41 PMID: 11132636
- 8. Fallica AN et al.. 2021. Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent In Vitro Antiproliferative Activity.. J Med Chem 64(18):13373-13393 PMID: 34472337
